Completed PHASE4 INTERVENTIONAL NCT00146302

Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?

BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth?

Sponsor: Bandim Health Project

Conditions Tuberculosis

Interventions Bacille Calmette Guerin (BCG)

Updated 5 times since 2017 Last updated: Mar 16, 2012 Started: Nov 30, 2002 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Tuberculosis, this trial is completed. The trial is conducted by Bandim Health Project and has accumulated 5 data snapshots since 2002. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bandim Health Project
International Cooperation with Developing Countries
Leiden University Medical Centre, DEPT of Parasitology, Leiden Holland
March of Dimes
Medical Research Council Unit, The Gambia

Data source: Bandim Health Project

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bissau, Guinea-Bissau